NCT00247988View on ClinicalTrials.gov

Weekly Carboplatin and Taxotere in Platinum Sensitive Relapsed Ovarian or Tubal or Primary Peritoneal Cancers

PHASE2TerminatedINTERVENTIONAL
Enrollment

38

Participants

Timeline

Start Date

October 31, 2003

Study Completion Date

April 30, 2007

Conditions
Platinum Sensitive Relapsed Ovarian Cancer
Interventions
DRUG

Weekly Taxotere with weekly carboplatin

Trial Locations (1)

S7N 4H4

Saskatoon Cancer Center, Saskatoon

Sponsors

Collaborators (1)

Sanofi
All Listed Sponsors
collaborator

Sanofi

INDUSTRY

lead

University of Saskatchewan

OTHER

NCT00247988 - Weekly Carboplatin and Taxotere in Platinum Sensitive Relapsed Ovarian or Tubal or Primary Peritoneal Cancers | Biotech Hunter | Biotech Hunter